Metabolites from the citrus extracts inhibit the activity of selected proteins in Indian Cobra (Naja naja) venom.


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
24 Apr 2020
Historique:
received: 12 04 2019
revised: 18 11 2019
accepted: 13 01 2020
pubmed: 19 1 2020
medline: 11 11 2020
entrez: 19 1 2020
Statut: ppublish

Résumé

Snakebite is a severe problem in many parts of the world, specifically in tropical and subtropical regions. A range of medicinal plant extracts are administered for treating snake bite. Of the many common plants, extracts of Citrus species have been documented to be used for treating snake bite and have been shown to decrease the snake venom toxicity. The aim of the current work is to evaluate the utility of citrus peel extracts (Citrus aurantium L. and Citrus reticulate Blanco) in the management of Indian cobra envenomation. Peels of citrus species were evaluated for their phospholipase A Citrus peel extracts are rich in polyphenols, flavonoids and tannins. The methanolic extract of Citrus aurantium L. and Citrus reticulate Blanco inhibits phospholipase (75%), protease (71%) and hemolysis (80%) activity of the venom. GC-MS analyses indicate the presence of β-sitosterol, n-hexadecanoic acid, eicosanoic acid, and flavone in both the extracts. In addition, C. reticulate extract contains α-tocopherol and squalene. Molecular docking revealed that α-tocopherol, spiro [androst-5-ene-17,1'-cyclobutan]-2'-one,3-hydroxy-(3β,17β)- and β-sitosterol acetate bind with moderate affinity to the catalytic site of phospholipase A2. The present study provides new molecular insight and scientific evidence on the utility of the methanolic extracts of citrus peels to neutralize the venom toxins of Naja naja.

Identifiants

pubmed: 31953201
pii: S0378-8741(19)31481-3
doi: 10.1016/j.jep.2020.112575
pii:
doi:

Substances chimiques

Elapid Venoms 0
Phospholipase A2 Inhibitors 0
Phytochemicals 0
Plant Extracts 0
Protease Inhibitors 0
Reptilian Proteins 0
Phospholipases A2 EC 3.1.1.4
Peptide Hydrolases EC 3.4.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112575

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there are no conflicts of interest.

Auteurs

Srimathi R (S)

School of Biosciences and Technology (SBST), Vellore Institute of Technology, Vellore, 632014, India. Electronic address: r.srimathi@vit.ac.in.

Jayaraman Gurunathan (J)

School of Biosciences and Technology (SBST), Vellore Institute of Technology, Vellore, 632014, India. Electronic address: gjayaraman@vit.ac.in.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH